About Alcentra Capital (NASDAQ:ABDC)
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million. Its investments range in size from $5 million to $15 million. Its investment objective is to generate both current income and capital appreciation primarily by making direct investments in lower middle-market companies in the form of senior debt, unitranche, second lien, subordinated debt and, to a lesser extent, senior debt and minority equity investments. Its investment focus is to make loans to, and selected equity investments in, privately-held lower-middle-market companies.
Industry, Sector and Symbol
Industry Investment advice
Sub-IndustryN/A
SectorFinance
SymbolNASDAQ:ABDC
CUSIPN/A
Phone212-922-8240
Debt
Debt-to-Equity RatioN/A
Current Ratio0.11%
Quick Ratio0.11%
Price-To-Earnings
Trailing P/E Ratio5.03
Forward P/E Ratio7.06
P/E GrowthN/A
Sales & Book Value
Annual Sales$33.35 million
Price / Sales2.83
Cash Flow$1.3663 per share
Price / Cash4.86
Book Value$11.07 per share
Price / Book0.60
Profitability
EPS (Most Recent Fiscal Year)$1.32
Net Income$-19,100,000.00
Net Margins-57.28%
Return on Equity10.56%
Return on Assets6.19%
Miscellaneous
EmployeesN/A
Outstanding Shares14,210,000
Alcentra Capital (NASDAQ:ABDC) Frequently Asked Questions
What is Alcentra Capital's stock symbol?
Alcentra Capital trades on the NASDAQ under the ticker symbol "ABDC."
How often does Alcentra Capital pay dividends? What is the dividend yield for Alcentra Capital?
Alcentra Capital declared a quarterly dividend on Thursday, March 15th. Investors of record on Friday, March 30th will be paid a dividend of $0.18 per share on Wednesday, April 4th. This represents a $0.72 dividend on an annualized basis and a yield of 10.84%. The ex-dividend date is Wednesday, March 28th. View Alcentra Capital's Dividend History.
How will Alcentra Capital's stock buyback program work?
Alcentra Capital announced that its Board of Directors has approved a share repurchase program on Friday, November 17th 2017, which permits the company to buyback $2,500,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its shares are undervalued.
How were Alcentra Capital's earnings last quarter?
Alcentra Capital (NASDAQ:ABDC) announced its quarterly earnings results on Wednesday, March, 14th. The asset manager reported $0.28 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.27 by $0.01. The asset manager earned $8.20 million during the quarter, compared to analysts' expectations of $7.77 million. Alcentra Capital had a negative net margin of 57.28% and a positive return on equity of 10.56%. View Alcentra Capital's Earnings History.
When is Alcentra Capital's next earnings date?
What price target have analysts set for ABDC?
5 brokers have issued 1 year target prices for Alcentra Capital's shares. Their predictions range from $7.00 to $15.00. On average, they expect Alcentra Capital's share price to reach $12.00 in the next twelve months. View Analyst Ratings for Alcentra Capital.
Who are some of Alcentra Capital's key competitors?
Some companies that are related to Alcentra Capital include MVC Capital (MVC), Howard Bancorp (HBMD), LCNB (LCNB), New Century Bancorp, Inc. (NC) (SLCT), Bank of Commerce (BOCH), Hallmark Financial Services (HALL), Kingstone Companies (KINS), AFH Financial Group (AFHP), Charles Stanley Group (CAY), First Financial Northwest (FFNW), 1st Constitution Bancorp (FCCY), FVCBankcorp (FVCB), Middlefield Banc (MBCN), First Community (FCCO), BayCom (BCML), BRT Realty Trust (BRT), Global Medical REIT (GMRE) and California First National Bancorp (CFNB).
Who are Alcentra Capital's key executives?
Alcentra Capital's management team includes the folowing people:
- Paul M.A. Hatfield, Chairman of the Board
- David Scopelliti, President, Chief Executive Officer, Director (Age 52)
- Ellida McMillan, Chief Financial Officer, Chief Operating Officer, Chief Accounting Officer, Treasurer, Secretary (Age 49)
- Branko Krmpotic, Executive Vice President
- Steven Reiff, Lead Independent Director
- T. Ulrich Brechbuhl, Director
- Douglas J. Greenlaw, Director
- Rudolph L. Hertlein, Director
Has Alcentra Capital been receiving favorable news coverage?
News coverage about ABDC stock has been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Alcentra Capital earned a coverage optimism score of 0.11 on Accern's scale. They also assigned press coverage about the asset manager an impact score of 45.50 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
How do I buy shares of Alcentra Capital?
Shares of ABDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Alcentra Capital's stock price today?
One share of ABDC stock can currently be purchased for approximately $6.64.
How big of a company is Alcentra Capital?
Alcentra Capital has a market capitalization of $95.46 million and generates $33.35 million in revenue each year. The asset manager earns $-19,100,000.00 in net income (profit) each year or $1.32 on an earnings per share basis.
How can I contact Alcentra Capital?
Alcentra Capital's mailing address is 200 PARK AVENUE 7TH FLOOR, NEW YORK NY, 10166. The asset manager can be reached via phone at 212-922-8240 or via email at [email protected]
MarketBeat Community Rating for Alcentra Capital (ABDC)
MarketBeat's community ratings are surveys of what our community members think about Alcentra Capital and other stocks. Vote "Outperform" if you believe ABDC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABDC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Alcentra Capital (NASDAQ:ABDC) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
5 Wall Street analysts have issued ratings and price targets for Alcentra Capital in the last 12 months. Their average twelve-month price target is $12.00, suggesting that the stock has a possible upside of 80.72%. The high price target for ABDC is $15.00 and the low price target for ABDC is $7.00. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.00 | 2.00 | 2.00 | 2.33 |
| Ratings Breakdown: | 1 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $12.00 | $12.00 | $12.8333 | $13.50 |
| Price Target Upside: | 80.72% upside | 91.08% upside | 52.96% upside | 18.73% upside |
Alcentra Capital (NASDAQ:ABDC) Consensus Price Target History
Alcentra Capital (NASDAQ:ABDC) Analyst Ratings History
Show:
(Data available from 4/20/2016 forward)
Alcentra Capital (NASDAQ:ABDC) Dividend Information
Alcentra Capital pays an annual dividend of $0.72 per share, with a dividend yield of 10.84%. ABDC's most recent quarterly dividend payment was Wednesday, April 4. Alcentra Capital pays out 54.55% of its earnings out as a dividend.
| Most Recent Dividend: | 4/4/2018 |
| Annual Dividend: | $0.72 |
| Dividend Yield: | 10.84% |
| Payout Ratio: | 54.55% (Trailing 12 Months of Earnings)
76.60% (Based on This Year's Estimates)
80.90% (Based on Next Year's Estimates)
|
Alcentra Capital (NASDAQ:ABDC) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 3/15/2018 | quarterly | $0.18 | 11.52% | 3/28/2018 | 3/30/2018 | 4/4/2018 |
| 11/6/2017 | Quarterly | $0.25 | 13.05% | 12/28/2017 | 12/29/2017 | 1/4/2018 |
| 8/4/2017 | quarterly | $0.34 | 11.96% | 9/28/2017 | 9/30/2017 | 10/5/2017 |
| 5/5/2017 | quarterly | $0.34 | 9.52% | 6/28/2017 | 6/30/2017 | 7/6/2017 |
| 3/10/2017 | quarterly | $0.34 | 10.49% | 3/29/2017 | 3/31/2017 | 4/6/2017 |
| 11/4/2016 | quarterly | $0.34 | 10.68% | 12/28/2016 | 12/31/2016 | 1/5/2017 |
| 8/5/2016 | quarterly | $0.34 | 11.05% | 9/28/2016 | 9/30/2016 | 10/6/2016 |
| 5/6/2016 | quarterly | $0.34 | 11.77% | 6/28/2016 | 6/30/2016 | 7/7/2016 |
| 3/9/2016 | quarterly | $0.34 | 12.75% | 3/29/2016 | 3/31/2016 | 4/7/2016 |
| 11/11/2015 | quarterly | $0.34 | 11.22% | 12/29/2015 | 12/31/2015 | 1/7/2016 |
| 8/12/2015 | quarterly | $0.34 | 10.73% | 9/28/2015 | 9/30/2015 | 10/6/2015 |
| 6/10/2015 | quarterly | $0.34 | 10.01% | 6/26/2015 | 6/30/2015 | 7/6/2015 |
| 3/18/2015 | quarterly | $0.34 | 9.81% | 3/27/2015 | 3/31/2015 | 4/6/2015 |
| 12/12/2014 | quarterly | $0.34 | 11.83% | 12/26/2014 | 12/30/2014 | 1/6/2015 |
| 8/12/2014 | quarterly | $0.34 | 10.3% | 9/26/2014 | 9/30/2014 | 10/6/2014 |
| 6/26/2014 | special | $0.1780 | | 6/26/2014 | 6/30/2014 | 7/7/2014 |
(Data available from 1/1/2013 forward)
Alcentra Capital (NASDAQ ABDC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 4.96%
Institutional Ownership Percentage: 34.87%
Alcentra Capital (NASDAQ ABDC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/23/2018 | Douglas J /Ma Greenlaw | Director | Buy | 1,000 | $7.15 | $7,150.00 | 1,000 |  |
| 3/20/2018 | Branko Krmpotic | Insider | Buy | 10,000 | $6.15 | $61,500.00 | 14,000 | |
| 3/20/2018 | David Scopelliti | CEO | Buy | 3,000 | $6.18 | $18,540.00 | 9,100 | |
| 3/20/2018 | Ellida Mcmillan | CFO | Buy | 750 | $6.13 | $4,597.50 | 2,600 | |
| 11/15/2017 | David Scopelliti | CEO | Buy | 1,500 | $7.10 | $10,650.00 | 6,100 | |
| 11/15/2017 | Ellida Mcmillan | CFO | Buy | 130 | $7.10 | $923.00 | 1,850 | |
| 11/15/2017 | T Ulrich Brechbuhl | Director | Buy | 3,200 | $7.03 | $22,496.00 | 6,800 | |
| 11/13/2017 | Steven H Reiff | Director | Buy | 6,900 | $7.23 | $49,887.00 | 35,246 | |
| 11/9/2017 | Paul J Echausse | Director | Sell | 10,000 | $7.45 | $74,500.00 | 58,946 | |
| 8/8/2017 | Ellida Mcmillan | CFO | Buy | 250 | $10.58 | $2,645.00 | 1,720 | |
| 8/7/2017 | Steven H Reiff | Director | Buy | 11,668 | $10.72 | $125,080.96 | 7,000 | |
| 5/22/2017 | Of New York Mellon Corp Bank | Major Shareholder | Sell | 1,691,839 | $13.13 | $22,213,846.07 | | |
| 12/2/2016 | Paul J Echausse | CEO | Buy | 1,800 | $11.49 | $20,682.00 | 68,946 | |
| 9/8/2016 | David Scopelliti | Insider | Buy | 2,000 | $12.88 | $25,760.00 | 4,600 | |
| 6/23/2016 | Ellida Mcmillan | CAO | Buy | 480 | $12.18 | $5,846.40 | 1,470 | |
| 5/20/2016 | Paul J Echausse | CEO | Buy | 1,200 | $11.89 | $14,268.00 | 67,146 | |
| 3/24/2016 | David Scopelliti | SVP | Buy | 500 | $11.27 | $5,635.00 | 2,600 | |
| 3/24/2016 | Ellida Mcmillan | CAO | Buy | 790 | $11.29 | $8,919.10 | 990 | |
| 3/24/2016 | Paul J Echausse | CEO | Buy | 800 | $11.45 | $9,160.00 | 65,946 | |
| 3/22/2016 | Paul J Echausse | CEO | Buy | 800 | $11.29 | $9,032.00 | 65,146 | |
| 3/18/2016 | David Scopelliti | SVP | Buy | 500 | $10.76 | $5,380.00 | 2,100 | |
| 3/17/2016 | David Scopelliti | SVP | Buy | 2,550 | $12.77 | $32,563.50 | 1,600 | |
| 3/17/2016 | Paul J Echausse | CEO | Buy | 800 | $10.84 | $8,672.00 | 64,346 | |
| 3/15/2016 | Paul J Echausse | CEO | Buy | 800 | $10.90 | $8,720.00 | 63,546 | |
| 9/24/2015 | Alcentra Investments Ltd | major shareholder | Sell | 1,475,620 | $12.89 | $19,020,741.80 | | |
| 8/14/2015 | Rudolph L Hertlein | Director | Buy | 1,400 | $12.88 | $18,032.00 | | |
| 6/23/2015 | David Scopelliti | SVP | Buy | 1,800 | $13.56 | $24,408.00 | | |
| 5/7/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 5,875 | $13.69 | $80,428.75 | | |
| 5/5/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 6,288 | $13.78 | $86,648.64 | | |
| 4/29/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 10,600 | $13.78 | $146,068.00 | | |
| 4/27/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 13,248 | $13.84 | $183,352.32 | | |
| 4/23/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 11,908 | $13.80 | $164,330.40 | | |
| 4/21/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 9,175 | $13.91 | $127,624.25 | | |
| 4/17/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 11,994 | $13.89 | $166,596.66 | | |
| 4/15/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 8,900 | $13.86 | $123,354.00 | | |
| 4/13/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 20,124 | $14.15 | $284,754.60 | | |
| 4/9/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 20,676 | $14.09 | $291,324.84 | | |
| 4/7/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 15,938 | $13.58 | $216,438.04 | | |
| 4/2/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 4,000 | $13.55 | $54,200.00 | | |
| 4/1/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 13,406 | $13.63 | $182,723.78 | | |
| 3/30/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 11,718 | $13.35 | $156,435.30 | | |
| 3/26/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 16,426 | $13.84 | $227,335.84 | | |
| 3/24/2015 | Of New York Mellon Corp Bank | Major Shareholder | Buy | 16,426 | $14.13 | $232,099.38 | | |
| 3/23/2015 | Paul J Echausse | CEO | Buy | 1,000 | $14.13 | $14,130.00 | | |
| 8/28/2014 | Paul J Echausse | CEO | Buy | 1,000 | $13.58 | $13,580.00 | | |
| 5/30/2014 | Paul J Echausse | CEO | Buy | 1,000 | $14.89 | $14,890.00 | | |
| 5/9/2014 | Rudolph L Hertlein | Director | Buy | 3,600 | $15.00 | $54,000.00 | | |
(Data available from 1/1/2013 forward)
Alcentra Capital (NASDAQ ABDC) News Headlines
| Source: |
|
Alcentra Capital (NASDAQ:ABDC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Alcentra Capital (NASDAQ:ABDC) Income Statement, Balance Sheet and Cash Flow Statement
Alcentra Capital (NASDAQ ABDC) Stock Chart for Friday, April, 20, 2018
Loading chart…
